Anaptysbio (ANAB) Interest Expenses (2016 - 2026)

Anaptysbio's Interest Expenses history runs 11 years deep, the most recent figure standing at $20.8 million for Q1 2026.

• Quarterly Interest Expenses rose 15.1% year-over-year to $20.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157.3 million (up 175.07% YoY) and the FY2025 annual result came in at $180.4 million, down 3.61% from the prior year.
• Interest Expenses was $20.8 million for Q1 2026 at Anaptysbio, down from $78.1 million in the prior quarter.
• Across five years, Interest Expenses topped out at $78.1 million in Q4 2025 and bottomed at -$1.8 million in Q4 2023.
• A 5-year average of $26.6 million and a median of $20.8 million in 2026 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses plunged 405.31% — and 2024, when it jumped 2359.96%.
• Anaptysbio's Interest Expenses stood at $584000.0 in 2022, then plunged by 405.31% to -$1.8 million in 2023, then soared by 2359.96% to $40.3 million in 2024, then jumped by 93.83% to $78.1 million in 2025, then plunged by 73.33% to $20.8 million in 2026.
• Business Quant data shows ANAB's Interest Expenses at $20.8 million in Q1 2026, $78.1 million in Q4 2025, and $68.5 million in Q3 2025.